Intravesical therapy for superficial bladder cancer: is it a wash?
KL Kilbridge and P Kantoff
JCO Jan 1 1994: 1–4. [PDF]
High-dose therapy: here to stay or just visiting?
GP Canellos
JCO Jan 1 1994: 5–6. [PDF]
	Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study
	F Boccardo, D Cannata, A Rubagotti, D Guarneri, A Decensi, L Canobbio, A Curotto, G Martorana, C Pegoraro, and F Selvaggi
	JCO Jan 1 1994: 7–13. [Abstract] [PDF]
	Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer
	TR Buroker, MJ O'Connell, HS Wieand, JE Krook, JB Gerstner, JA Mailliard, PL Schaefer, R Levitt, CG Kardinal, and DH Gesme, Jr
	JCO Jan 1 1994: 14–20. [Abstract] [PDF]
	Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group
	CG Moertel, LL Gunderson, JA Mailliard, PJ McKenna, JA Martenson, Jr, PA Burch, and SS Cha
	JCO Jan 1 1994: 21–27. [Abstract] [PDF]
	Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34- positive peripheral-blood progenitors and growth factors on engraftment
	EJ Shpall, RB Jones, SI Bearman, WA Franklin, PG Archer, T Curiel, M Bitter, HN Claman, SM Stemmer, and M Purdy
	JCO Jan 1 1994: 28–36. [Abstract] [PDF]
	Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study
	LJ Ayash, A Elias, C Wheeler, E Reich, G Schwartz, R Mazanet, I Tepler, D Warren, C Lynch, and R Gonin
	JCO Jan 1 1994: 37–44. [Abstract] [PDF]
	Reinduction with the same cytostatic treatment in patients with metastatic breast cancer: an Eastern Cooperative Oncology Group study
	G Falkson, R Gelman, J Glick, CI Falkson, and J Harris
	JCO Jan 1 1994: 45–49. [Abstract] [PDF]
	Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice- daily tamoxifen regimens for breast cancer [published erratum appears in J Clin Oncol 1994 Jun;12(6):1337]
	AU Buzdar, GN Hortobagyi, D Frye, D Ho, DJ Booser, V Valero, FA Holmes, BK Birmingham, K Bui, and C Yeh
	JCO Jan 1 1994: 50–54. [Abstract] [PDF]
	Phase II trial of bleomycin, ifosfamide, and carboplatin in metastatic cervical cancer
	AM Murad, SA Triginelli, and JC Ribalta
	JCO Jan 1 1994: 55–59. [Abstract] [PDF]
	Oral etoposide is active against platinum-resistant epithelial ovarian cancer
	PJ Hoskins and KD Swenerton
	JCO Jan 1 1994: 60–63. [Abstract] [PDF]
	Prognostic significance of p53 immunostaining in epithelial ovarian cancer
	LC Hartmann, KC Podratz, GL Keeney, NA Kamel, JH Edmonson, JP Grill, JQ Su, JA Katzmann, and PC Roche
	JCO Jan 1 1994: 64–69. [Abstract] [PDF]
	Sequencing and schedule effects of cisplatin plus etoposide in small- cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial
	AW Maksymiuk, JR Jett, JD Earle, JQ Su, FA Diegert, JA Mailliard, CG Kardinal, JE Krook, MH Veeder, and M Wiesenfeld
	JCO Jan 1 1994: 70–76. [Abstract] [PDF]
	Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer
	DW Miles, O Fogarty, CM Ash, RM Rudd, CW Trask, SG Spiro, WM Gregory, JA Ledermann, RL Souhami, and PG Harper
	JCO Jan 1 1994: 77–82. [Abstract] [PDF]
	Phase I/II and pharmacologic study of long-term continuous infusion etoposide combined with cisplatin in patients with advanced non-small- cell lung cancer
	H Kunitoh and K Watanabe
	JCO Jan 1 1994: 83–89. [Abstract] [PDF]
	Phase I study of irinotecan and cisplatin with granulocyte colony- stimulating factor support for advanced non-small-cell lung cancer
	N Masuda, M Fukuoka, S Kudoh, Y Kusunoki, K Matsui, K Nakagawa, T Hirashima, M Tamanoi, T Nitta, and T Yana
	JCO Jan 1 1994: 90–96. [Abstract] [PDF]
	Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects
	RM Bukowski, GT Budd, JA Gibbons, RJ Bauer, A Childs, J Antal, J Finke, L Tuason, V Lorenzi, and D McLain
	JCO Jan 1 1994: 97–106. [Abstract] [PDF]
	Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule
	JA Talcott, A Whalen, J Clark, PP Rieker, and R Finberg
	JCO Jan 1 1994: 107–114. [Abstract] [PDF]
	MDR-1 expression and response to vincristine, doxorubicin, and dexamethasone chemotherapy in multiple myeloma refractory to alkylating agents
	JJ Cornelissen, P Sonneveld, M Schoester, HG Raaijmakers, HK Nieuwenhuis, AW Dekker, and HM Lokhorst
	JCO Jan 1 1994: 115–119. [Abstract] [PDF]
	Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients
	PJ Mencel, RJ Motzer, M Mazumdar, V Vlamis, DF Bajorin, and GJ Bosl
	JCO Jan 1 1994: 120–126. [Abstract] [PDF]
	Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group
	ME Nesbit, Jr, JD Buckley, SA Feig, JR Anderson, B Lampkin, ID Bernstein, TH Kim, S Piomelli, JH Kersey, and PF Coccia
	JCO Jan 1 1994: 127–135. [Abstract] [PDF]
	Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in children with acute leukemia
	J Weinthal, JD Frost, G Briones, and MS Cairo
	JCO Jan 1 1994: 136–140. [Abstract] [PDF]
	Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in patients with refractory lymphoma undergoing autologous bone marrow transplantation
	M Attal, P Canal, D Schlaifer, E Chatelut, A Dezeuze, F Huguet, C Payen, J Pris, and G Laurent
	JCO Jan 1 1994: 141–148. [Abstract] [PDF]
	Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases
	SC Tang, L Visser, B Hepperle, J Hanson, and S Poppema
	JCO Jan 1 1994: 149–154. [Abstract] [PDF]
	Transdermal clonidine for ameliorating tamoxifen-induced hot flashes [published erratum appears in J Clin Oncol 1996 Aug;14(8):2411]
	RM Goldberg, CL Loprinzi, JR O'Fallon, MH Veeder, AW Miser, JA Mailliard, JC Michalak, AM Dose, KM Rowland, Jr, and NL Burnham
	JCO Jan 1 1994: 155–158. [Abstract] [PDF]
	Unilateral nephrectomy and cisplatin as risk factors of ifosfamide- induced nephrotoxicity: analysis of 120 patients
	R Rossi, A Godde, A Kleinebrand, M Riepenhausen, J Boos, J Ritter, and H Jurgens
	JCO Jan 1 1994: 159–165. [Abstract] [PDF]
	Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer
	DI Jodrell, LM Reyno, R Sridhara, MA Eisenberger, KH Tkaczuk, EG Zuhowski, VJ Sinibaldi, MJ Novak, and MJ Egorin
	JCO Jan 1 1994: 166–175. [Abstract] [PDF]
	Phase I clinical and pharmacokinetic study of high-dose mitoxantrone combined with carboplatin, cyclophosphamide, and autologous bone marrow rescue: high response rate for refractory ovarian carcinoma
	PJ Stiff, RS McKenzie, DS Alberts, JA Sosman, JR Dolan, N Rad, and T McCloskey
	JCO Jan 1 1994: 176–183. [Abstract] [PDF]
	Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors
	JL Murray, JE Cunningham, H Brewer, K Mujoo, AA Zukiwski, DA Podoloff, LP Kasi, V Bhadkamkar, HA Fritsche, and RS Benjamin
	JCO Jan 1 1994: 184–193. [Abstract] [PDF]
	Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione
	HH Bailey, RT Mulcahy, KD Tutsch, RZ Arzoomanian, D Alberti, MB Tombes, G Wilding, M Pomplun, and DR Spriggs
	JCO Jan 1 1994: 194–205. [Abstract] [PDF]
	Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy
	RA Rabinovitch, MJ Zelefsky, JJ Gaynor, and Z Fuks
	JCO Jan 1 1994: 206–212. [Abstract] [PDF]
	The cancer anorexia-cachexia syndrome
	KA Nelson, D Walsh, and FA Sheehan
	JCO Jan 1 1994: 213–225. [Abstract] [PDF]
Consensus Conference on Intensive Chemotherapy Plus Hematopoietic Stem- Cell Transplantation in Malignancies: Lyon, France, June 4-6, 1993
B Coiffier, T Philip, AK Burnett, and ML Symann
JCO Jan 1 1994: 226–231. [PDF]
WR-2721 and hypocalcemia
N O'Rourke, E McCloskey, and J Kanis
JCO Jan 1 1994: 232. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.